• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Kulicke and Soffa Industries Inc.

    11/8/24 12:47:51 PM ET
    $KLIC
    Semiconductors
    Technology
    Get the next $KLIC alert in real time by email
    SC 13G/A 1 kulickesoffaindustries13g-.htm SC 13G/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 2) *

    KULICKE AND SOFFA INDUSTRIES, INC.
    (Name of Issuer)


    COMMON STOCK
    (Title of Class of Securities)

    501242101
    (CUSIP Number)

    SEPTEMBER 30, 2024
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    X    Rule 13d-1(b)
    ☐    Rule 13d-1(c)
    ☐    Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    image_4.jpg


    Page 1 of 8 Pages



    image_4.jpgCUSIP No. 501242101
    1.Names of Reporting Persons
    American Century Investment Management, Inc.
    image_4.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_4.jpg
    3.SEC Use Only

    image_4.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power

    2,464,281
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,541,468
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,541,468

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐
     
           11.

    Percent of Class Represented by Amount in Row (9)

    4.66%

    12.

    Type of Reporting Person (See Instructions)

    IA



    Page 2 of 8 Pages



    image_4.jpgCUSIP No. 501242101
    1.Names of Reporting Persons
    American Century Companies, Inc.
    image_4.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_4.jpg
    3.SEC Use Only

    image_4.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power
    2,464,281
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,541,468
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,541,468

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    4.66%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 3 of 8 Pages



    image_4.jpgCUSIP No. 501242101
    1.Names of Reporting Persons
    Stowers Institute for Medical Research
    image_4.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_4.jpg
    3.SEC Use Only

    image_4.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power
    2,464,281
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    2,541,468
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    2,541,468

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    4.66%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 4 of 8 Pages



    Item 1.
    a)Name of Issuer

    Kulicke and Soffa Industries, Inc.

    b)Address of Issuer’s Principal Executive Offices

    23A Serangoon North Avenue 5
    #01-01 Singapore, Singapore 554369
    Item 2.
    a)Name of Person Filing:
    1)American Century Investment Management, Inc.
    2)American Century Companies, Inc.
    3)Stowers Institute for Medical Research

    a)Address of Principal Business Office or, if none, Residence.
    4500 Main Street
    9th Floor
    Kansas City, Missouri 64111

    c)Citizenship.
    1)Delaware
    2)Delaware
    3)Delaware

    d)Title of Class of Securities
    Reference is made to the cover page of this filing.

    e)CUSIP Number.
    Reference is made to the cover page of this filing.




    Page 5 of 8 Pages



    Item 3.    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    1)American Century Investment Management, Inc. is an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
    2)American Century Companies, Inc. is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    3)Stowers Institute for Medical Research is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).

    Item 4.     Ownership.
         Reference is made to Items 5-9 and 11 on the cover page of this filing.
    Item 5. Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ X ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule.  Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
    See attached Exhibit A.
    Item 8. Identification and Classification of Members of the Group.
    Not applicable.
    Item 9. Notice of Dissolution of Group
    Not applicable






    Page 6 of 8 Pages



    Item 10. Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated this 8th day of November, 2024.

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak______________
        John Pak
        Senior Vice President, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown_______
        Richard W. Brown
        Chairman

    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b).

    EXHIBIT A
    This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. (“ACC”), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the “Subject Securities”).  American Century Investment Management, Inc. (“ACIM”) is a wholly-owned subsidiary of ACC and an investment adviser registered under §203 of the Investment Advisers Act of 1940.
    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1) Agreement.




    Page 7 of 8 Pages



    EXHIBIT B
    Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.

    Dated this 8th day of November, 2024.

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak______________
        John Pak
        Senior Vice President, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown_______
        Richard W. Brown
        Chairman











    Page 8 of 8 Pages

    Get the next $KLIC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KLIC

    DatePrice TargetRatingAnalyst
    5/7/2025$50.00 → $36.00Hold
    TD Cowen
    11/15/2024$45.00 → $50.00Hold
    TD Cowen
    11/15/2024$55.00Hold → Buy
    Needham
    8/8/2024$52.00 → $45.00Hold
    TD Cowen
    11/17/2023$60.00Hold → Buy
    Craig Hallum
    8/10/2023$55.00Buy → Hold
    Craig Hallum
    4/12/2022$80.00 → $59.00Buy → Neutral
    B. Riley Securities
    2/4/2022Buy → Hold
    Needham
    More analyst ratings

    $KLIC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kong Peter T M bought $47,510 worth of shares (1,000 units at $47.51), increasing direct ownership by 1% to 92,072 units (SEC Form 4)

      4 - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Issuer)

      5/8/24 8:24:10 PM ET
      $KLIC
      Semiconductors
      Technology

    $KLIC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Kulicke & Soffa Reports Second Quarter 2025 Results

      SINGAPORE, May 6, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced financial results of its second fiscal quarter ended March 29, 2025. The Company reported second quarter net revenue of $162.0 million, net loss of $84.5 million, representing EPS of $(1.59) per fully diluted share, and non-GAAP net loss of $27.9 million, representing non-GAAP EPS of $(0.52) per fully diluted share. On March 31, 2025, the Company disclosed that its Board of Directors had approved a plan related to the intended cessation of its Electronics Assembly ("EA") equipment business. During the second fiscal quarter 2025, pre-tax

      5/6/25 4:05:00 PM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke & Soffa Schedules Second Quarter 2025 Conference Call for 8:00 AM ET, May 7th, 2025

      SINGAPORE, April 22, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa", "K&S" or the "Company"), a global leader in semiconductor assembly technology, today announced that a conference call is scheduled to discuss the Company's second fiscal quarter 2025 financial results and its business outlook, on Wednesday, May 7, 2025, at 8:00 am ET. The Company will issue its second fiscal quarter 2025 financial results in the evening of Tuesday, May 6, 2025, at approximately 4:00 pm ET. To access the conference call, interested parties may call +1-877-407-8037 or internationally +1-201-689-8037. A live webcast and replay of the webcast will also be available at

      4/22/25 9:05:00 AM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke & Soffa Introduces New Vertical Wire Solutions to Expand Market Leadership

      Elevating Memory Density with ATPremier MEM PLUS™ SINGAPORE, March 25, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa", "K&S", "we" or the "Company") announced the launch of ATPremier MEM PLUS, serving high-volume memory applications. The innovative ATPremier MEM PLUS™ is a cutting-edge wafer level packaging solution, deploying innovative vertical wire technology to address emerging advanced memory applications within today's fast-paced semiconductor market. Engineered for high-volume, at-the-edge AI applications, K&S' vertical wire technology has broken barriers to enable a new level of transistor-dense DRAM and NAND assembly. The Company anticipate

      3/25/25 4:30:00 PM ET
      $KLIC
      Semiconductors
      Technology

    $KLIC
    Leadership Updates

    Live Leadership Updates

    See more
    • Kulicke & Soffa Appoints Denise M. Dignam to its Board of Directors

      SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa," "K&S" or the "Company") today announced the appointment of Denise M. Dignam to its Board of Directors. Ms. Dignam serves as President of The Chemours Company (NYSE:CC) (Chemours) Titanium Technologies (TT) business, one of the largest manufacturers of Titanium Dioxide (TiO2) in the world. She has over 35 years of chemical industry experience across multiple areas including commercialization, sales and marketing, strategy, supply chain and operations leadership. Ms. Dig

      8/23/23 9:05:00 AM ET
      $CC
      $KLIC
      Major Chemicals
      Industrials
      Semiconductors
      Technology
    • Kulicke & Soffa Appoints Jon Olson to its Board of Directors

      SINGAPORE, March 5, 2021 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S" or the "Company") today announced the appointment of Jon A. Olson to its Board of Directors. Mr. Olson, a seasoned executive with over 40 years of semiconductor industry experience, has provided strategic insight and financial decision making at Intel Corporation and later at Xilinx, Inc. He currently serves as Director on the Board of Xilinx, Inc. and previously Director and Audit Committee Chair of Mellanox Technologies, InvenSense, Inc. and Home Union, Inc. Mr. Olson has a robust track record of strategic leadership supporting capital allocation, M&A, profitability improvem

      3/5/21 9:05:00 AM ET
      $KLIC
      Semiconductors
      Technology

    $KLIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Kulicke and Soffa Industries Inc.

      SC 13G/A - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Subject)

      11/12/24 4:03:12 PM ET
      $KLIC
      Semiconductors
      Technology
    • Amendment: SEC Form SC 13G/A filed by Kulicke and Soffa Industries Inc.

      SC 13G/A - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Subject)

      11/8/24 12:47:51 PM ET
      $KLIC
      Semiconductors
      Technology
    • Amendment: SEC Form SC 13G/A filed by Kulicke and Soffa Industries Inc.

      SC 13G/A - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Subject)

      11/4/24 1:29:39 PM ET
      $KLIC
      Semiconductors
      Technology

    $KLIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on Kulicke & Soffa with a new price target

      TD Cowen reiterated coverage of Kulicke & Soffa with a rating of Hold and set a new price target of $36.00 from $50.00 previously

      5/7/25 12:47:18 PM ET
      $KLIC
      Semiconductors
      Technology
    • TD Cowen reiterated coverage on Kulicke & Soffa with a new price target

      TD Cowen reiterated coverage of Kulicke & Soffa with a rating of Hold and set a new price target of $50.00 from $45.00 previously

      11/15/24 8:07:53 AM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke & Soffa upgraded by Needham with a new price target

      Needham upgraded Kulicke & Soffa from Hold to Buy and set a new price target of $55.00

      11/15/24 7:54:23 AM ET
      $KLIC
      Semiconductors
      Technology

    $KLIC
    Financials

    Live finance-specific insights

    See more

    $KLIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $KLIC
    SEC Filings

    See more
    • Kulicke & Soffa Reports Second Quarter 2025 Results

      SINGAPORE, May 6, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced financial results of its second fiscal quarter ended March 29, 2025. The Company reported second quarter net revenue of $162.0 million, net loss of $84.5 million, representing EPS of $(1.59) per fully diluted share, and non-GAAP net loss of $27.9 million, representing non-GAAP EPS of $(0.52) per fully diluted share. On March 31, 2025, the Company disclosed that its Board of Directors had approved a plan related to the intended cessation of its Electronics Assembly ("EA") equipment business. During the second fiscal quarter 2025, pre-tax

      5/6/25 4:05:00 PM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke & Soffa Schedules Second Quarter 2025 Conference Call for 8:00 AM ET, May 7th, 2025

      SINGAPORE, April 22, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa", "K&S" or the "Company"), a global leader in semiconductor assembly technology, today announced that a conference call is scheduled to discuss the Company's second fiscal quarter 2025 financial results and its business outlook, on Wednesday, May 7, 2025, at 8:00 am ET. The Company will issue its second fiscal quarter 2025 financial results in the evening of Tuesday, May 6, 2025, at approximately 4:00 pm ET. To access the conference call, interested parties may call +1-877-407-8037 or internationally +1-201-689-8037. A live webcast and replay of the webcast will also be available at

      4/22/25 9:05:00 AM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke & Soffa Declares Quarterly Dividend of $0.205

      SINGAPORE, March 6, 2025 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa," "K&S" or the "Company"), today announced that its Board of Directors has approved a quarterly dividend of $0.205 per share of common stock. The dividend payment will be made on April 8, 2025, to shareholders of record as of March 20, 2024. About Kulicke & Soffa Founded in 1951, Kulicke & Soffa specializes in developing cutting-edge semiconductor and electronics assembly solutions enabling a smart and more sustainable future. Our ever-growing range of products and services supports growth and facilitates technology transitions across large-scale markets, such as advanced display, aut

      3/6/25 9:05:00 AM ET
      $KLIC
      Semiconductors
      Technology
    • Director Dignam Denise was granted 1,343 shares, increasing direct ownership by 22% to 7,312 units (SEC Form 4)

      4 - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Issuer)

      4/3/25 7:34:33 PM ET
      $KLIC
      Semiconductors
      Technology
    • Director Milzcik Gregory F was granted 1,343 shares, increasing direct ownership by 2% to 74,845 units (SEC Form 4)

      4 - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Issuer)

      4/3/25 7:32:54 PM ET
      $KLIC
      Semiconductors
      Technology
    • Director Kong Peter T M was granted 1,343 shares, increasing direct ownership by 1% to 96,329 units (SEC Form 4)

      4 - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Issuer)

      4/3/25 7:31:14 PM ET
      $KLIC
      Semiconductors
      Technology
    • SEC Form 10-Q filed by Kulicke and Soffa Industries Inc.

      10-Q - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Filer)

      5/7/25 8:56:02 AM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke and Soffa Industries Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Filer)

      5/6/25 4:05:21 PM ET
      $KLIC
      Semiconductors
      Technology
    • Kulicke and Soffa Industries Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments, Regulation FD Disclosure

      8-K - KULICKE & SOFFA INDUSTRIES INC (0000056978) (Filer)

      3/31/25 4:51:02 PM ET
      $KLIC
      Semiconductors
      Technology